| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a9e6421e9257148abad101e1ce6c162 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4412
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-407
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437 |
| filingDate |
2005-04-20^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_121926c0ab1c3c37795c4fe4c4227c2a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5271f83c7293a6ca03552b938d7543a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51c2ac53c549d83fca2c9e15326da11c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c6b20ffc0a201e3179b83f2d889d57d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_650673e59b62a050ce66c4d24194628e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b7a4863d0c9a0b1498faaddcb407c9c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d40c129865b9b550a654c81d56375de |
| publicationDate |
2007-10-16^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
BR-PI0510060-A |
| titleOfInvention |
pyridoindolone derivatives substituted for -6, their preparation and their application in |
| abstract |
PIRIDOINDOLONA DERIVATIVES REPLACED IN -6, THEIR PREPARATION AND THERAPY APPLICATION FOR THERAPEUTICS. The present invention has as object objects which respond to the formula: wherein: R1 represents a hydrogen atom; a (C 1 -C 4) alkyl group; a group - (CH 2 -) - m - OH; a group - (CH 2 -) - m - CN; a group - (CH ~ 2 ~) ~ m ~ NR ~ 9 ~ R ~ 10 ~; R 2 represents a hydrogen atom or a (C 1 -C 4) alkyl group; R 3 represents a phenyl substituted by R 6, R 7, R 8; R 4 represents: a group COPY (A) on the SUMMARY PAGE; a heterocyclic radical chosen from: - R 5 - represents a hydrogen atom or a (C 1 -C 4) alkyl group. Process of preparation and application in therapy. |
| priorityDate |
2004-04-21^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |